about
Use of a German longitudinal prescription database (LRx) in pharmacoepidemiologyMulti-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based studyComparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.Acute mania associated with levetiracetam treatment.Geographic variation in the age- and gender-specific prevalence and incidence of epilepsy: analysis of Taiwanese National Health Insurance-based data.Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.Antiepileptic use for epilepsy and nonepilepsy disorders: A population-based study (1998-2013).The role of phenytoin in the treatment of localization related epilepsy: an international internet-based survey of neurologists and epileptologists.Safety aspects of antiepileptic drugs--focus on pharmacovigilance.Efficacy of phenytoin, valproic acid, carbamazepine and new antiepileptic drugs on control of late-onset post-stroke epilepsy in Taiwan.Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia.Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.SCN1A variations and response to multiple antiepileptic drugs.Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman.Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011.
P2860
Q26785420-46FA4A2A-2471-4D84-9CBC-A4DBB97DA7F1Q28538150-FCB7B500-AC51-432C-890C-92C8458968B4Q30970793-290290A3-208C-4880-A283-1D73FBCD7AB3Q33887278-B2F5BEA4-6B36-4794-834B-FC983889BA11Q34086019-9E802174-41A8-438B-89A6-E1E84B57A235Q35684841-61E02CB1-D07C-4002-B7AE-ECA1D3E2F5F5Q36347356-15CD1E25-F74F-4FC7-8155-D6CA1E79A17FQ36661735-B50B7B6B-3D9D-4663-AD67-AC5FF1869FE2Q37018882-9A36F83F-CC60-40A5-B79D-FC3C912F4949Q37954227-4E6CA172-1C7B-43D2-A834-27A0AF067338Q40764900-2E74BB79-11B2-4737-AFDD-4F74670E99B8Q41338021-FF3FC363-58D7-4F91-8BB4-F448A228AA57Q43843541-3F80BD2D-6A11-4674-8E3D-F2C153849210Q45016382-95A0BEAF-6B5E-4D1D-B0C6-71CE0780F7EFQ46489939-04FAFB0E-1C51-418D-B8E2-74583C5379A8Q46814329-26673E97-001E-4B37-867E-08FEE34BFDF9
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Antiepileptic drugs in Australia: 2002-2007.
@en
Antiepileptic drugs in Australia: 2002-2007.
@nl
type
label
Antiepileptic drugs in Australia: 2002-2007.
@en
Antiepileptic drugs in Australia: 2002-2007.
@nl
prefLabel
Antiepileptic drugs in Australia: 2002-2007.
@en
Antiepileptic drugs in Australia: 2002-2007.
@nl
P356
P1476
Antiepileptic drugs in Australia: 2002-2007.
@en
P2093
Mervyn J Eadie
P356
10.1002/PDS.1871
P577
2010-01-01T00:00:00Z